Evaluation of Physical-Chemical and Microbiological Stability of Fluconazole Oral Suspensions for Hospital Use
DOI:
https://doi.org/10.22456/2527-2616.103473Keywords:
Fluconazole, Analytical Method Suitability, Formulation Development, Formulation StabilityAbstract
Fluconazole is an important drug in the treatment of cutaneous and systemic mycoses. The Hospital de Clínicas de Porto Alegre performs a derivation of fluconazole capsules to obtain an oral liquid formulation that is easily administered and whose dose can be adjusted. In order to replace the derivation for a formulation produced from an active pharmaceutical ingredient, this study sought to develop a liquid oral formulation, evaluate its physical chemical and microbiological stability and demonstrate suitability of the analytical method for the formulation assay. Seven different formulations of pharmaceutical suspension form were produced and evaluated for pH, viscosity, sedimentation volume and assay. The analytical method by High Performance Liquid Chromatography was demonstrated. Two most promising formulations were manipulated in the Farmácia Semi-Industrial do Hospital de Clínicas de Porto Alegre and stored in amber PET bottles under three different conditions: room temperature, under refrigeration (2 to 8 ºC) and in an oven (40 ° C). Samples were collected after 0, 7 and 14 days to evaluate physical-chemical stability, assay, pH and macroscopic aspects. Samples were collected after 0 and 21 days to evaluate microbiological stability. It was possible to demonstrate stability for one of the formulations for a 14-day period. Throughout the study, the chosen formulation presented adequate quantification of fluconazole, constant pH, no organoleptic changes and no microbial growth. The results suggest the incorporation of a new formulation for fluconazole to the Farmacia Semi-Industrial portfolio).
Downloads
References
Castro G, et al. Time-of-flight mass spectrometry assessment of fluconazole and climbazole UV and UV/H2O2 degradability: Kinetics study and transformation products elucidation. Water Research, 2015; 681-690.
Bourichia H, et al. Solid-state characterization and impurities determination of fluconazol generic products marketed in Morocco. Journal of Pharmaceutical Analysis. 2012; 412-421.
Cyr TD, et al. Spectral characterization of fluconazole. Journal of Pharmaceutical and Biomedical Analysis. 1996; 247-255.
Dentinger PJ, Swenson, C. F. Stability of Reconstituted Fluconazole Oral Suspension in Plastic. The Annals of Pharmacotherapy. 2009; 285- 289.
Hurtado FK, et al. Microbiological Assay and HPLC Method for the Determination of Fluconazole in Pharmaceutical Injectable Formulations. Latin American Journal of Pharmacy. 2008; 224-228.
Sweetman, SC. Martindale: The Complete Drug Reference. 36. ed. London: Rps Publishing; 2009.
Ayers MV et al.. Evaluation of the stability of Vigabatrin in hospitalar extemporaneous formulations. Drug Analytical Research, 2019; 51- 60.
BRASIL. Resolução RDC n° 318, de 06 de novembro de 2019. Estabelece os critérios para a realização de Estudos de Estabilidade de insumos farmacêuticos ativos e medicamentos, exceto biológicos, e dá outras providências. Diário Oficial União. 07 nov 2019.
Gobetti C. Avaliação da Estabilidade de Derivação Farmacêutica Hospitalar de Tizanidina. Porto Alegre: Universidade Federal do Rio Grande do Sul, 2017. Dissertação de Mestrado em Ciências Farmacêuticas.
Nahata MC, Loyd V, Allen J. Extemporaneous Drug Formulations. Clinical Therapeutics, 2008; 2112- 2119.
Costa PQ, Lima JES, Coelho HLL. Prescrição e preparo de medicamentos sem formulação adequada para crianças: um estudo de base hospitalar. Brazilian Journal of Pharmaceutical Sciences, 2009; 57-66.
Peterlini MAS, Chaud MN, Pedreira MLG. Órfãos de terapia medicamentosa: a administração de medicamentos por via intravenosa em crianças hospitalizadas. Rev Latino-am Enfermagem, 2003; 11(1):88-95.
Giam JÁ, Mclachilan AJ. Extemporaneous product use in paediatric patients: a systematic review. International Journal of Pharmacy Practice, 2008; 3- 10.
USP 41. The United States Pharmacopeia. 41. ed. Rockville: United States Pharmacopeia Convention, 2017.
Allen LV, Popovich NG, Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 9. ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
AOAC INTERNATIONAL, Guidelines for standard method performance requirements – Appendix f. AOAC official methods of analysis, 2016.
Downloads
Published
Versions
- 12-03-2026 (2)
- 16-07-2020 (1)
How to Cite
Issue
Section
License
Copyright (c) 2020 Drug Analytical Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.





